from: Boshoff et al (2004). The transcriptional responses of Mycobacterium tuberculosis to inhibitors of metabolism. J Biol Chem.

Gene Expression Profile for Rv1569/bioF1

LFCtreatmentdescriptionclass of inhibitor

0.747

Amikacinug/mL Amikacintranslation

0.208

Cap5-10ug/mL Capreomycintranslation

0.261

Rox10-50 ug/mL Roxithromycintranslation

-0.343

SM2-5 ug/mL Streptomycintranslation

0.201

Tet5-10 ug/mL Tetracyclinetranslation

0.031

Rif0.2-5ug/mL Rifampicintranscription

-0.380

Rifp0.1-0.5ug/mL Rifapentinetranscription

-1.384

Min_med__succinate_Minimal medium with succinate as sole carbon source as compared to growth in 7H9/ADC/Tween/glycerolstarvation

-0.918

CCCP10-50 uM Carbonyl cyanide 3-chlorophenylhydrazonerespiration

-0.388

CPZ10-50 ug/mL Chlorpromazinerespiration

-0.804

Clofazimine10-13 ug/mL Clofaziminerespiration

-0.310

Clotrimazole10-24 ug/mL Clotrimazole (azole drug)respiration

-1.006

DCCD20-100 uM Dicyclohexylcarbodiimiderespiration

-1.128

DNP"0.5-2.5 mM 2,4-Dinitrophenol"respiration

0.063

DTT"1-2 mM 1,4-Dithio-DL-threitol"respiration

-0.647

Econazole10-24 ug/mL Econazole (azole drug)respiration

0.196

GSNO_CFZ0.1 mM S-Nitrosoglutathione + 5 ug/mL Clofaziminerespiration

0.180

GSNO_CPZ0.1 mM S-Nitrosoglutathione + 20-25 ug/mL Chlorpromazinerespiration

-0.252

GSNO_KCN0.1mM S-Nitrosoglutathione + 5ug/mL potassium cyaniderespiration

-0.302

GSNO_menadione0.1 mM S-Nitrosoglutathione + 6-10 ug/mL menadionerespiration

0.139

KCN5-20 ug/mL Potassium cyaniderespiration

0.469

NaN30.2-2 mM Sodium aziderespiration

-1.028

Nigericin50 uM Nigericinrespiration

-0.494

TRC10-150 ug/mL Triclosanrespiration

-1.091

TRZ10-25 ug/mL Thioridazinerespiration

-0.541

Valinomycin0.5-10 uM Valinomycinrespiration

-0.763

ZnSO42 mM ZnSO4respiration

0.037

menadione6-10 ug/mL Menadionerespiration

-0.153

Ascididemin_Nat_prod4-9 ug/mL Organic extract of Eudistoma amplumironLimitation

-0.235

Deferoxamine150-250 uM Deferoxamine mesylateironLimitation

-0.259

Dipyridyl"100-200 uM 2,2'-Bipyridyl"ironLimitation

-0.216

GSNO0.02-0.1mM S-NitrosoglutathionedosRassociated

-0.215

NRP_1Non-replicating persistence stage 1dosRassociated

-0.223

Amp0.2mg/mL AmpicillincellWall

-0.163

Cephalexin20-100 ug/mL CephalexincellWall

-0.144

Cerulenin0.32-5 ug/mL CerulenincellWall

0.040

DIPED5-100 ug/mL DiisopropylethylenediaminecellWall

-0.165

EMB10-20 ug/mL EthambutolcellWall

0.237

Eta12-40 ug/mL EthionamidecellWall

0.650

INH0.2-0.4 ug/mL IsoniazidcellWall

0.314

TLM0.1-0.2 mg/mL ThiolactomycincellWall

-0.852

PalmitateMinimal medium with palmitate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

-0.603

SuccinateMinimal medium with succinate as sole C-source as compared to minimal medium with glucose as sole CsourcecarbonSource

0.403

BZA0.12 mg/mL BenzamidearomaticAmides

0.168

Nam0.12 - 1.2 mg/mL NicotinamidearomaticAmides

1.270

PZA0.12-1.2 mg/mL PyrazinamidearomaticAmides

0.030

H2O24 mM hydrogen peroxideDNAdamaging

0.482

Levo10 ug/mL LevofloxacinDNAdamaging

0.287

Mtm0.1-0.2 ug/mL Mitomycin CDNAdamaging

-0.002

Novobiocin10 ug/mL NovobiocinDNAdamaging

0.969

Oflox5-10 ug/mL OfloxacinDNAdamaging

0.769

UVUV-irradiationDNAdamaging

0.162

ARP41-4 ug/mL Antitubercular compound ARP4?

-0.419

Antimycin12.5-50 ug/mL Antimycin A?

-0.035

DTNB"1-2 mM 5,5'-Dithiobis(2-nitrobenzoic acid)"?

-0.118

PA_110-50 ug/mL Antitubercular compound PA-1?

-0.478

PA_2110-50 ug/mL Antitubercular compound PA-21?

1.823

PA8240.2-2 ug/mL PA-824?

0.665

Procept_677620-30 ug/mL Antitubercular compound Procept 6776?

0.511

Procept_67785-40 ug/mL Antitubercular compound Procept 6778?

-0.729

Verapamil50 uM Verapamil?

0.427

mercaptoethanol2 mM 2-Mercaptoethanol?

-0.343

methoxatin10-20 ug/mL Methoxatin?